Research & Development
Medicare paid $704.2M for drug testing at risk of noncompliance with requirements
In an audit, the Office of Inspector General identified Medicare Part B payments for drug testing services that were at risk for noncompliance with Medicare requirements.
March 1, 2023
Axim Biotechnologies developing point-of-care assay to measure fentanyl neutralizing antibodies
Recent research suggests that fentanyl neutralizing antibodies may prevent overdose deaths, but scientists will need to quantitatively measure a patient's neutralizing antibodies through clinical studies and for relapse prevention.
January 18, 2023
GBS to acquire drug screening firm Intelligent Fingerprinting
The acquisition would enable the combination of Intelligent Fingerprinting's sweat-based drug screening technology with the GBS saliva-based glucose biosensor platform and manufacturing expertise, GBS said.
June 15, 2022
Scientists develop new rapid, onsite THC assay
The THC assay -- dubbed express probe for onsite cannabis inhalation (EPOCH) -- can detect the compound with high sensitivity and provide results within five minutes, according to the research group, led by Hojeong Yu, PhD, of Harvard Medical School.
October 28, 2021
Beckman Coulter launches DxU Iris urinalysis system at AACC
DxU Iris is designed to reduce manual sample processing in urinalysis lab workflow by reducing manual reviews to 4%. This can cut sample processing time by up to 78%, according to the company.
September 27, 2021
Abnormal urine drug tests common in cancer patients
Approaches vary for monitoring cancer patients who are prescribed opioids on a long-term basis. Patients may be selected on a random basis, or, alternatively, screening may be focused on those with a higher likelihood of abuse.
February 6, 2020
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Patients prefer immediate test results, even when the news is bad
Quest Diagnostics offers suite of services for transplant patients and living donors
Siemens expands opioid testing menu with fentanyl assay
The test is capable of detecting fentanyl and its principal metabolite norfentanyl. Being able to identify both fentanyl and norfentanyl prolongs the time window for detecting fentanyl in urine with chemistry analyzers, giving laboratories more time to identify true positives, according to the company.
January 15, 2020
CDC finds vitamin E acetate in 100% of vaping cases
The discovery reinforces suspicion that vitamin E acetate is the cause of a series of cases of what the CDC has dubbed EVALI (e-cigarette, or vaping, product use-associated lung injury). It is believed that the substance is added to cannabinoid products sold online that have not been approved by the U.S. Food and Drug Administration.
November 7, 2019
Abbott, Intoximeters partner on roadside drug test
The SoToxa mobile test uses a swab from the mouth, cheek, and gums, and results are available within five minutes, according to Abbott. The company is positioning the product as a more convenient alternative to blood testing.
August 14, 2019
AACC: Labs should be aware of false positives on THC drug screens
Cannabinol (CBN), which is marketed as an over-the-counter sleep aid, gave a positive result on one of two THC immunoassays tested in a study of urine samples taken at ARUP Laboratories, a nationwide clinical and anatomical pathology reference laboratory and a nonprofit arm of the University of Utah. Specifically, CBN gave a positive result on the Emit II Plus assay on a Beckman Coulter AU5810 instrument, but it did not give a positive result with the Microgenics MultiGent test on the Abbott Architect product, the researchers reported.
August 5, 2019
AACC calls for joint effort to tackle opioid epidemic
The number of fatal overdoses caused by synthetic opioids increased by 46% in the U.S. from 2016 to 2017 and formed a large proportion of the roughly 70,000 drug overdose deaths in 2017, according to the AACC. Clinical laboratories have the experts, tools, and tests to identify synthetic opioids that are otherwise generally missed.
August 4, 2019
MedTest Dx to launch new Clinitox line at AACC 2019
Targeted at labs that perform confirmation testing, the new Clinitox Calibrators and Controls line is designed to eliminate the need to acquire and set up materials, perform multiple handling and measuring steps, and manage controls and certifications.
July 31, 2019
Page 1 of 2